FDAnews
FDAnews Drug Daily Bulletin

EUFLEXXA LABELING EXTENDED TO INCLUDE ROOM TEMPERATURE STORAGE

April 11, 2006

Ferring Pharmaceuticals Inc. announced recently that the U.S. Food and Drug Administration (FDA) has approved the Premarket Application (PMA) supplement for EUFLEXXA (highly purified hyaluronan) that allows the product to be stored at room temperature, as well as refrigerated. EUFLEXXA is a three-injection treatment given by physicians for the pain caused by knee osteoarthritis
(OA).
PR Newswire